Screener
Alto Neuroscience ANRO Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Alto Neuroscience’s reported figures.
Based on trailing twelve months.
The source filing: Alto Neuroscience’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001999480-26-000012
FAQ
- What is Alto Neuroscience's return on equity?
- Alto Neuroscience (ANRO) reported return on equity of -38.9% in Q1 2026.
- How has Alto Neuroscience's return on equity changed year-over-year?
- Alto Neuroscience's return on equity decreased by 2.1% year-over-year, from -38% to -38.9%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Alto Neuroscience's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude